Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adicon HoldingsADCNF 75 Return-on-Tangible-Asset is -0.41% as of Dec. 2025. GuruFocus rates ADCNF with a GF Score™ of 75/100 and a GF Value™ of $1.19. The stock has 6 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Adicon Holdings ranks better than 58.22% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Adicon Holdings's annualizedNet Income for the quarter that ended in Dec. 2025 was $-2.5 Mil. Adicon Holdings's average total tangible assets for the quarter that ended in Dec. 2025 was $617.8 Mil. Therefore, Adicon Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was -0.41%.
The historical rank and industry rank for Adicon Holdings's Return-on-Tangible-Asset or its related term are showing as below:
ADCNF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.42 Med: 7.82 Max: 17.04
Current: 0.42
During the past 6 years, Adicon Holdings's highest Return-on-Tangible-Asset was 17.04%. The lowest was 0.42%. And the median was 7.82%.
ADCNF's Return-on-Tangible-Asset is ranked better than 58.22% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.4
vs ADCNF: 0.42
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Adicon Holdings Return-on-Tangible-Asset Related Terms
Adicon Holdings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Adicon Holdings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADCNF vs TMO, DHR, IDXX: Return-on-Tangible-Asset Comparison
For the Diagnostics & Research subindustry, Adicon Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adicon Holdings Return-on-Tangible-Asset vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Adicon Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of -0.41% mean?
Adicon Holdings (ADCNF) has a Return-on-Tangible-Asset of -0.41% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Adicon Holdings and its competitors. Over the past decade, Adicon Holdings' Return-on-Tangible-Asset has ranged from 0.42 to 17.04. According to the industry distribution chart, Adicon Holdings ranks #89 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 41.8%.
Is Adicon Holdings' Return-on-Tangible-Asset too high?
Adicon Holdings' current Return-on-Tangible-Asset is -0.41%. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 17.04. Based on the distribution chart, Adicon Holdings ranks #89 out of 213 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Adicon Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Adicon Holdings' Return-on-Tangible-Asset compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Adicon Holdings ranks #89 out of 213 companies for Return-on-Tangible-Asset. This puts Adicon Holdings in the upper half of its industry. Historically, Adicon Holdings' own Return-on-Tangible-Asset has ranged from 0.42 to 17.04 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Diagnostics & Research company?
A good Return-on-Tangible-Asset depends on the Medical Diagnostics & Research industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Adicon Holdings and its competitors. Adicon Holdings's current Return-on-Tangible-Asset is -0.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicon Holdings stock overvalued right now?
Adicon Holdings (ADCNF) has a current Return-on-Tangible-Asset of -0.41%. The stock's GF Value™ is $1.19, compared to a current price of $0.65 — trading 45.4% below its estimated fair value. The current Return-on-Tangible-Asset is -0.41%. Adicon Holdings' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Adicon Holdings (ADCNF), the current Return-on-Tangible-Asset is -0.41% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adicon Holdings (ADCNF) Overvalued in 2026?
Based on GuruFocus' analysis, Adicon Holdings stock appears to be undervalued.
The current stock price of $0.65 is trading 45.4% below its estimated GF Value™ of $1.19.
Key valuation signals for ADCNF:
Return-on-Tangible-Asset: -0.41%
GF Value™: $1.19 vs. price of $0.65 (45.4% below fair value)
No single metric tells the full story. See the ADCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adicon Holdings Ltd is a ICL service provider in China. It offers comprehensive testing services to hospitals and health check centers through an integrated network of self-operated laboratories across China. Its testing services platform includes clinical laboratories, pathology laboratories, reproductive genetics laboratories, gene laboratories, and mass spectrometry laboratories, consisting of over 4,000 medical diagnostic tests, the introduction of over 300 new high-end diagnostic tests.
75GF Score
Get the complete analysis for ADCNF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADCNF has been successfully added to your 
